$82.44
$0.00 (0.00%)
End-of-day quote: 05/04/2024
NasdaqGS:BMRN
BioMarin Pharmaceutical Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$2.42B | $2.10B | $1.85B | $1.86B | $1.70B | $1.49B | $1.31B | $1.12B | $889.90M | $749.28M | $548.49M | $500.72M | $441.36M | $376.27M | $324.66M | $296.49M | $121.58M | $84.21M | $25.67M | $18.64M | |
| GM % | Gross Margin % |
|
47.85% | 45.93% | 40.46% | 38.06% | 36.95% | 32.16% | 35.10% | 21.97% | 11.58% | 22.08% | 19.20% | 21.30% | 32.39% | 42.17% | 44.24% | 50.83% | 20.25% | 10.37% | -129.93% | -188.27% | |
| OM | Operating Margin |
|
7.11% | 2.19% | -4.03% | -4.93% | -6.15% | -10.40% | -9.41% | -23.41% | -34.83% | -19.31% | -25.63% | -18.92% | -8.09% | 1.67% | 5.06% | 13.41% | -47.12% | -51.57% | -296.28% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $2.08 | $1.93 | $1.33 | $1.63 | $0.93 | $0.51 | $0.42 | $-0.22 | $-0.89 | $-1.35 | $-1.08 | $-0.95 | $-0.46 | $1.75 | $0.00 | $0.34 | $-0.16 | $-0.34 | $-1.08 | $-1.30 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 | 0.00% | 0 | 0.00% | -0.00% | -0.00% | -0.00% | 0 | |
| Sha. | Shares |
|
188.6m | 186.25m | 183.91m | 181.74m | 179.84m | 178.25m | 175.84m | 172.65m | 161.53m | 149.09m | 143.46m | 125.81m | 114.79m | 110.63m | 100.96m | 99.87m | 97.11m | 91.73m | 74.3m | 64.5m | |
| OCF | Operating Cash Flow |
|
$159.26M | $175.90M | $304.54M | $85.37M | $48.26M | $20.21M | $-8.76M | $-227.84M | $-219.50M | $-70.42M | $-57.34M | $17.61M | $18.42M | $18.75M | $87.73M | $-9.18M | $-35.03M | $-52.27M | $-59.15M | $-54.30M | |
| FCF | Free Cash Flow |
|
$405.68M | $54.94M | $208.96M | $-28.95M | $-96.76M | $-124.41M | $-207.98M | $-376.22M | $-449.34M | $-192.37M | $-124.76M | $-26.96M | $-54.47M | $-30.71M | $-2.07M | $-65.55M | $-57.44M | $-76.85M | $-65.64M | $-75.12M | |
| FCFS | Free Cash Flow Per Share |
|
$0.27 | $0.24 | $1.01 | $0.08 | $-0.64 | $-0.70 | $-0.48 | $-2.27 | $-2.56 | $-0.82 | $-0.89 | $-0.22 | $-1.21 | $-0.30 | $-0.02 | $-0.66 | $-0.60 | $-0.91 | $-0.95 | $-1.17 |
